Proteomic and Transcriptomic Analyses Reveal Pathological Changes in the Entorhinal Cortex Region that Correlate Well with Dysregulation of Ion Transport in Patients with Alzheimer's Disease
- PMID: 33904022
- DOI: 10.1007/s12035-021-02356-3
Proteomic and Transcriptomic Analyses Reveal Pathological Changes in the Entorhinal Cortex Region that Correlate Well with Dysregulation of Ion Transport in Patients with Alzheimer's Disease
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder. The earliest neuropathology of AD appears in entorhinal cortex (EC) regions. Therapeutic strategies and preventive measures to protect against entorhinal degeneration would be of substantial value in the early stages of AD. In this study, transcriptome based on the Illumina RNA-seq and proteome based on TMT-labelling were performed for RNA and protein profiling on AD EC samples and non-AD control EC samples. Immunohistochemistry was used to validate proteins expressions. After integrated analysis, 57 genes were detected both in transcriptome and proteome data, including 51 in similar altering trends (7 upregulated, 44 downregulated) and 6 in inverse trends when compared AD vs. control. The top 6 genes (GABRG2, CACNG3, CACNB4, GABRB2, GRIK2, and SLC17A6) within the 51 genes were selected and related to "ion transport". Correlation analysis demonstrated negative relationship of protein expression level with the neuropathologic changes. In conclusion, the integrate transcriptome and proteome analysis provided evidence for dysregulation of ion transport across brain regions in AD, which might be a critical signaling pathway that initiates pathology. This study might provide new insight into the earliest changes occurring in the EC of AD and novel targets for AD prevention and treatment.
Keywords: Alzheimer’s disease; Entorhinal cortex; Ion transport; Pathological changes; Proteomics; Transcriptomics.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.Biol Open. 2021 Jan 25;10(1):bio056796. doi: 10.1242/bio.056796. Biol Open. 2021. PMID: 33495355 Free PMC article. Review.
-
Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length.J Neurosci. 2023 May 17;43(20):3764-3785. doi: 10.1523/JNEUROSCI.2102-22.2023. Epub 2023 Apr 13. J Neurosci. 2023. PMID: 37055180 Free PMC article.
-
Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.Hereditas. 2021 Jul 9;158(1):25. doi: 10.1186/s41065-021-00190-0. Hereditas. 2021. PMID: 34243818 Free PMC article.
-
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs.Genes (Basel). 2022 Apr 15;13(4):703. doi: 10.3390/genes13040703. Genes (Basel). 2022. PMID: 35456509 Free PMC article.
-
Network activity changes in the pathophysiology of Alzheimer's disease: the role of aging and early entorhinal cortex dysfunction.Metab Brain Dis. 2022 Feb;37(2):289-298. doi: 10.1007/s11011-021-00848-8. Epub 2021 Sep 30. Metab Brain Dis. 2022. PMID: 34591222 Review.
Cited by
-
Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity.G3 (Bethesda). 2023 Aug 30;13(9):jkad132. doi: 10.1093/g3journal/jkad132. G3 (Bethesda). 2023. PMID: 37311212 Free PMC article.
-
A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.J Alzheimers Dis. 2024;97(1):145-162. doi: 10.3233/JAD-231034. J Alzheimers Dis. 2024. PMID: 38073390 Free PMC article.
-
Proteoform Analysis of the Human Olfactory System: A Window into Neurodegenerative Diseases.Proteomes. 2024 Mar 21;12(1):9. doi: 10.3390/proteomes12010009. Proteomes. 2024. PMID: 38535507 Free PMC article. Review.
-
Single-cell analysis reveals transcriptomic reprogramming in aging primate entorhinal cortex and the relevance with Alzheimer's disease.Aging Cell. 2022 Nov;21(11):e13723. doi: 10.1111/acel.13723. Epub 2022 Sep 27. Aging Cell. 2022. PMID: 36165462 Free PMC article.
-
Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia.Aging Dis. 2024 Aug 1;15(4):1748-1770. doi: 10.14336/AD.2023.1201. Aging Dis. 2024. PMID: 38300642 Free PMC article. Review.
References
-
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dementia : the journal of the Alzheimer's Association 7(3):270–279. https://doi.org/10.1016/j.jalz.2011.03.008 - DOI
-
- Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr et al (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dementia : the journal of the Alzheimer's Association 7(3):280–292. https://doi.org/10.1016/j.jalz.2011.03.003 - DOI
-
- Mielke MM, Vemuri P, Rocca WA (2014) Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol 6:37–48. https://doi.org/10.2147/clep.s37929 - DOI - PubMed - PMC
-
- Spires-Jones TL, Hyman BT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron 82(4):756–771. https://doi.org/10.1016/j.neuron.2014.05.004 - DOI - PubMed - PMC
-
- Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P et al (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2):207–216. https://doi.org/10.1016/s1474-4422(12)70291-0 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
- 81971023/National Natural Science Foundation of China
- 81801114/National Natural Science Foundation of China
- 81801180/National Natural Science Foundation of China
- 2017-I2M-3-008/CAMS Innovation Fund for Medical Sciences
- 2019-RC-HL-006/Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical